European Expansion Sanity Group is actively expanding its European footprint across Germany, Switzerland, Poland, the UK, and Czechia and seeks cultivation partners worldwide to scale supply. Sales opportunities include exclusive supply agreements, contract farming, and co-branded medical cannabinoid products to feed EU markets.

Medical Manufacturing As a pharmaceutical grade cannabis operator, Sanity offers contract manufacturing, private label, and white label opportunities with cultivation networks to accelerate EU access to cannabinoids and wellbeing products.

Retail Footprint Sanity is piloting Swiss recreational cannabis and expanding its Basel presence, plus a Poland CMK partnership to bring hemp products to pharmacies, signaling strong European retail distribution opportunities for partner products and private label lines.

Investment Readiness With investment from Organigram and ongoing growth, Sanity demonstrates openness to strategic alliances, co investments, and joint ventures to fund and accelerate expansion, presenting a path for co funded distribution and market entry deals.

Integrated Health Tech Sanity's portfolio spans medicinal cannabinoids, consumer health, and technology, creating opportunities for integrated product ecosystems, cross selling between pharma grade medicines and wellness lines, and potential digital health collaborations.